Shane Tatar
Medical · Merrick, NYNPI 1770932303
Payments from drug & device makers
Across 98 payments — averaging $26.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$661
- AbbVie$632
- GSK$292
- Intra-sana Laboratories$232
- Lilly USA, LLC$138
- AstraZeneca$81
- plus $540 from 20 others
What the payments were for
- Food & beverage$2,576100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $661 |
| AbbVie | 15 | $632 |
| GSK | 10 | $292 |
| Intra-sana Laboratories | 3 | $232 |
| Lilly USA, LLC | 8 | $138 |
| AstraZeneca | 4 | $81 |
| Amarin Pharma, Inc. | 3 | $58 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Amgen | 2 | $54 |
| Merck | 3 | $51 |
| Arbor Pharmaceuticals, Inc. | 2 | $39 |
| Johnson & Johnson | 2 | $34 |
| Dexcom, Inc. | 1 | $23 |
| Clarus Therapeutics Inc. | 2 | $22 |
| Abbott | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Heartflow, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$244
- UBRELVY$223
- Reltone 200 Mg$132
- GLYCATE$132
- Reltone 400 Mg$132
- TRELEGY ELLIPTA$120
- QULIPTA$105
How this compares
$2,576 in reported general payments places this provider in the 80th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $43,904 |
| EliquisApixaban | 13 | $20,372 |
| TrulicityDulaglutide | 12 | $19,856 |
| SynthroidLevothyroxine Sodium | 25 | $2,234 |
| Atorvastatin Calcium | 131 | $1,328 |
| Rosuvastatin Calcium | 77 | $1,056 |
| Levothyroxine Sodium | 82 | $1,029 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $795 |
| Metoprolol Succinate | 44 | $637 |
| Famotidine | 25 | $536 |
| Losartan Potassium | 57 | $524 |
| Amlodipine Besylate | 83 | $389 |
| Metformin Hcl | 54 | $350 |
| Montelukast Sodium | 23 | $298 |
| Tamsulosin Hcl | 22 | $287 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $661 | $43,90424 claims |
| Lilly USA, LLCTrulicity | $138 | $19,85612 claims |
| AbbVieSynthroid | $632 | $2,23425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,395 medical providers in New York.
Other medical in Merrick
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.